Viking (VIK) Stock Price, News & Analysis

Company Overview

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for metabolic and endocrine disorders. The company’s pipeline comprises small-molecule hormone receptor modulators designed to address conditions such as obesity, type 2 diabetes, non-alcoholic steatohepatitis (NASH) and other liver diseases. By leveraging proprietary chemistry and target validation, Viking seeks to advance multiple candidates from preclinical research through proof-of-concept studies.

Founded in 2012 and headquartered in San Diego, California, Viking Therapeutics emerged as a spin-out focused on nuclear hormone receptor programs. The company completed its initial public offering in 2013 and began trading on the NYSE American under the ticker VIK. Since inception, Viking has collaborated with academic institutions and clinical research organizations across North America and Europe to conduct Phase 1 and Phase 2 trials, positioning its lead candidates for broader registration efforts in key global markets.

Viking’s research platform emphasizes selective modulation of thyroid hormone and fibroblast growth factor receptors, aiming to improve metabolic balance while minimizing off-target effects. In addition to its development programs, the company maintains ongoing preclinical efforts to expand its portfolio into related indications, potentially addressing muscle wasting and other catabolic disorders. Its scientific team is complemented by strategic partnerships that support scale-up, formulation and regulatory planning.

The company is led by a management group with decades of experience in pharmaceutical R&D and corporate strategy. Viking’s executive leadership and board members have held senior roles at global biopharma companies and bring expertise in clinical development, commercial planning and regulatory affairs. Together, they guide Viking’s efforts to translate innovative science into therapies that may benefit patients with challenging metabolic diseases.

Key Stats

• Today's Range: $54.16 to $55.60
• 50-Day Range: $40.27 to $54.44
• 52-Week Range: $30.56 to $55.57
• Volume: 785,168 shs
• Average Volume: 2.61 million shs
• Market Capitalization: $24.59 billion
• P/E Ratio: 45.08
• Dividend Yield: N/A
• Price Target: $49.87
• Consensus Rating: Moderate Buy

Viking Stock Analysis - MarketRank™

Viking scored higher than 74% of companies evaluated by MarketBeat, and ranked 104th out of 295 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Viking has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 10 buy ratings, 5 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Viking has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 55.03%

Earnings Growth

Earnings for Viking are expected to grow by 55.03% in the coming year, from $1.49 to $2.31 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Viking is 45.08, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.45.

Price to Earnings Ratio vs. Sector

The P/E ratio of Viking is 45.08, which means that it is trading at a more expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 21.02.

Price to Earnings Growth Ratio

Viking has a PEG Ratio of 0.66. PEG Ratios below 1 indicate that a company could be undervalued.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.36% of the float of Viking has been sold short.

Short Interest Ratio / Days to Cover

Viking has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Viking has recently decreased by 24.48%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Viking does not currently pay a dividend.

Dividend Growth

Viking does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.36% of the float of Viking has been sold short.

Short Interest Ratio / Days to Cover

Viking has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Viking has recently decreased by 24.48%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.37

News Sentiment

Viking has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Consumer Discretionary companies.

News Coverage This Week

MarketBeat has tracked 27 news articles for Viking this week, compared to 17 articles on an average week.

Search Interest

9 people have searched for VIK on MarketBeat in the last 30 days. This is an increase of 13% compared to the previous 30 days.

MarketBeat Follows

Only 5 people have added Viking to their MarketBeat watchlist in the last 30 days. This is a decrease of -29% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Viking insiders have not sold or bought any company stock.

Percentage Held by Institutions

98.84% of the stock of Viking is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

VIK Stock Analysis - Frequently Asked Questions

How have VIK shares performed this year?

Viking's stock was trading at $44.06 on January 1st, 2025. Since then, VIK shares have increased by 25.9% and is now trading at $55.4860.
View the best growth stocks for 2025 here.

How were Viking's earnings last quarter?

Viking Holdings Ltd. (NYSE:VIK) issued its quarterly earnings results on Tuesday, May, 20th. The company reported ($0.24) EPS for the quarter, topping analysts' consensus estimates of ($0.26) by $0.02. The company's revenue for the quarter was up 24.9% on a year-over-year basis.
Read the conference call transcript.

When did Viking IPO?

Viking (VIK) raised $1.5 billion in an IPO on Wednesday, May 1st 2024. The company issued 64,041,668 shares at $24.00 per share.

Who are Viking's major shareholders?

Viking's top institutional shareholders include Central Pacific Bank Trust Division.

How do I buy shares of Viking?

Shares of VIK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Viking own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Viking investors own include Invesco QQQ (QQQ), SPDR Dow Jones Industrial Average ETF Trust (DIA), Intel (INTC), SPDR S&P 500 ETF Trust (SPY), NVIDIA (NVDA), Meta Platforms (META) and Taiwan Semiconductor Manufacturing (TSM).

Company Calendar

• Last Earnings: 5/20/2025
• Today: 7/03/2025
• Next Earnings (Estimated): 8/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Discretionary
• Industry: LEISURE&REC SVS
• Sub-Industry: Transportation
• Current Symbol: NYSE:VIK
• Previous Symbol: NYSE:VIK
• CIK: 1745201
• Web: www.viking.com
• Phone: 441-478-2244
• Fax: N/A
• Employees: 12,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $49.87
• High Stock Price Target: $61.00
• Low Stock Price Target: $39.00
• Potential Upside/Downside: -8.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 15 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.23
• Trailing P/E Ratio: 44.26
• Forward P/E Ratio: 36.54
• P/E Growth: 0.66
• Net Income: $152.33 million
• Net Margins: 9.60%
• Pretax Margin: 10.10%
• Return on Equity: -128.44%
• Return on Assets: 7.99%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.63
• Quick Ratio: 0.61

Sales & Book Value

• Annual Sales: $5.33 billion
• Price / Sales: 4.52
• Cash Flow: $2.50 per share
• Price / Cash Flow: 21.77
• Book Value: ($0.51) per share
• Price / Book: -106.75

Miscellaneous

• Outstanding Shares: 443,140,000
• Free Float: N/A
• Market Cap: $24.12 billion
• Optionable: Optionable
• Beta: 2.38